HIGHLIGHTS
- who: Pedro Romero from the Department of Fundamental Oncology, Faculty of Biology and Medicine, University of Lausanne, Epalinges, Switzerland have published the research: Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control, in the Journal: (JOURNAL)
- what: In this context, the authors aimed to target to Xcr1+ DCs tumor antigens in the form of SLP genetically fused or not to the Xcl1 chemokine. The aim of this study was to develop a strategy to harness these essential cross-presenting DCs. The study shows the monitoring of tumor growth over a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.